KOE:328130

Lunit Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-07 22:18 UTC

Last close

n/aKRW

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
-35.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-56.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-65.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.81Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Safety is the furthest below its sector's middle: 0.22 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.15x

0.80x

1.35x

3.45x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales3.15x
Its own average over 7 years, 26.36B.
Profit0.80x
Its own average over 7 years, -58.48B.
Free cash flow1.35x
Its own average over 7 years, -40.50B.
Debt3.45x
Its own average over 7 years, 32.36B.
Pricen/a
Its own average over 0 years. Market data

Debt is furthest from its own average, at 3.45 times.

The filed years, as a table

Each line is 100 at 2019-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2019-12-31	100.0	100.0
2020-12-31	720.8	118.1
2021-12-31	3,346.2	0.0
2022-12-31	6,988.7	345.9
2023-12-31	12,641.1	398.4
2024-12-31	27,307.9	355.9
2025-12-31	41,899.2	502.7

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: KRW

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: KRW

Figures behind the shape

Growth

125.4%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate125.4%
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
One-year change in net income43.4%
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Returns on capital

-35.3%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capital-35.3%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity-33.9%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-12.6%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

-17.2%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin-17.2%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-100.0%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-56.1%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-65.7%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

7.3x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
Price to book7.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio12.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.81

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity0.81
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.26
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score-0.05
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.